Skip to Main Content

Paper Details

Efficacy and safety of sodium-glucose cotransporter-2 inhibitors for heart failure with mildly reduced or preserved ejection fraction: a systematic review and meta-analysis of randomized controlled trials.
Front Cardiovasc Med
0
2023
HF, HFmrEF, HFpEF, SGLT2i, cardiovascular, cardiovascular death, glucose, heart failure, patients, sodium-, sodium-glucose cotransporter-2
Author NameAffiliation
Sourbha S DaniLahey Hospital and Medical Center
Marat FudimDuke University Medical Center
Marat FudimDuke Clinical Research Institute
Gregg C FonarowAhmanson-university of california los angeles Cardiomyopathy Center, University of California Los Angeles
Gregg C FonarowAhmanson-university of california los angeles Cardiomyopathy Center, University of California Los Angeles
  • 1 - 5

Datasets

PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink